These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 15231203)

  • 21. [Prevalence of antibody to hepatitis C virus in 177 drug addicts].
    Ye S
    Zhonghua Liu Xing Bing Xue Za Zhi; 1993 Feb; 14(1):45-8. PubMed ID: 8389248
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Acute hepatitis C in a contemporary US cohort: modes of acquisition and factors influencing viral clearance.
    Wang CC; Krantz E; Klarquist J; Krows M; McBride L; Scott EP; Shaw-Stiffel T; Weston SJ; Thiede H; Wald A; Rosen HR
    J Infect Dis; 2007 Nov; 196(10):1474-82. PubMed ID: 18008226
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prevalence of, and risk factors for, hepatitis C virus infection among recent initiates to injecting in London and Glasgow: cross sectional analysis.
    Judd A; Hutchinson S; Wadd S; Hickman M; Taylor A; Jones S; Parry JV; Cameron S; Rhodes T; Ahmed S; Bird S; Fox R; Renton A; Stimson GV; Goldberg D
    J Viral Hepat; 2005 Nov; 12(6):655-62. PubMed ID: 16255768
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hepatitis C virus infection: prevalence, risk factors, and prevention opportunities among young injection drug users in Chicago, 1997-1999.
    Thorpe LE; Ouellet LJ; Levy JR; Williams IT; Monterroso ER
    J Infect Dis; 2000 Dec; 182(6):1588-94. PubMed ID: 11069228
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Needle sharing in regular sexual relationships: an examination of serodiscordance, drug using practices, and the gendered character of injecting.
    Bryant J; Brener L; Hull P; Treloar C
    Drug Alcohol Depend; 2010 Mar; 107(2-3):182-7. PubMed ID: 19942380
    [TBL] [Abstract][Full Text] [Related]  

  • 26. High prevalence of hepatitis C virus infection in the largest province of Pakistan.
    Idrees M; Lal A; Naseem M; Khalid M
    J Dig Dis; 2008 May; 9(2):95-103. PubMed ID: 18419643
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Evaluation of a pilot study on needle and syringe exchange program among injecting drug users in a community in Guangdong, China].
    Lin P; Fan ZF; Yang F; Wu ZY; Wang Y; Liu YY; Ming ZQ; Li WJ; Luo W; Fu XB; Mai XR; Xu RH; Feng WY; He Q
    Zhonghua Yu Fang Yi Xue Za Zhi; 2004 Sep; 38(5):305-8. PubMed ID: 15498241
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prevalence of hepatitis B and C among HIV positive patients in Georgia and its associated risk factors.
    Badridze N; Chkhartishvili N; Abutidze A; Gatserelia L; Sharvadze L
    Georgian Med News; 2008 Dec; (165):54-60. PubMed ID: 19124918
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The influence of needle exchange programs on injection risk behaviors and infection with hepatitis C virus among young injection drug users in select cities in the United States, 1994-2004.
    Holtzman D; Barry V; Ouellet LJ; Des Jarlais DC; Vlahov D; Golub ET; Hudson SM; Garfein RS
    Prev Med; 2009 Aug; 49(1):68-73. PubMed ID: 19410600
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prevalence of HIV, hepatitis C and syphilis among injecting drug users in Russia: a multi-city study.
    Rhodes T; Platt L; Maximova S; Koshkina E; Latishevskaya N; Hickman M; Renton A; Bobrova N; McDonald T; Parry JV
    Addiction; 2006 Feb; 101(2):252-66. PubMed ID: 16445554
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evidence for a substantial role of sharing of injecting paraphernalia other than syringes/needles to the spread of hepatitis C among injecting drug users.
    Mathei C; Shkedy Z; Denis B; Kabali C; Aerts M; Molenberghs G; Van Damme P; Buntinx F
    J Viral Hepat; 2006 Aug; 13(8):560-70. PubMed ID: 16901287
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Individual and couple-level risk factors for hepatitis C infection among heterosexual drug users: a multilevel dyadic analysis.
    McMahon JM; Pouget ER; Tortu S
    J Infect Dis; 2007 Jun; 195(11):1572-81. PubMed ID: 17471426
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hepatitis C virus (HCV)--specific T cell responses in injection drug users with apparent resistance to HCV infection.
    Thurairajah PH; Hegazy D; Chokshi S; Shaw S; Demaine A; Kaminski ER; Naoumov NV; Cramp ME
    J Infect Dis; 2008 Dec; 198(12):1749-55. PubMed ID: 18959498
    [TBL] [Abstract][Full Text] [Related]  

  • 34. High prevalence of hepatitis C virus infection among noninjecting drug users: association with sharing the inhalation implements of crack.
    Macías J; Palacios RB; Claro E; Vargas J; Vergara S; Mira JA; Merchante N; Corzo JE; Pineda JA
    Liver Int; 2008 Jul; 28(6):781-6. PubMed ID: 18312289
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Modelling the force of infection for hepatitis B and hepatitis C in injecting drug users in England and Wales.
    Sutton AJ; Gay NJ; Edmunds WJ; Hope VD; Gill ON; Hickman M
    BMC Infect Dis; 2006 Jun; 6():93. PubMed ID: 16762050
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Social structural and behavioral underpinnings of hyperendemic hepatitis C virus transmission in drug injectors.
    Brewer DD; Hagan H; Sullivan DG; Muth SQ; Hough ES; Feuerborn NA; Gretch DR
    J Infect Dis; 2006 Sep; 194(6):764-72. PubMed ID: 16941342
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Association of sex, hygiene and drug equipment sharing with hepatitis C virus infection among non-injecting drug users in New York City.
    Howe CJ; Fuller CM; Ompad DC; Galea S; Koblin B; Thomas D; Vlahov D
    Drug Alcohol Depend; 2005 Sep; 79(3):389-95. PubMed ID: 16102381
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Co-infection by human immuno deficiency virus, hepatitis B and hepatitis C virus in injecting drug users.
    Devi KhS; Brajachand N; Singh HL; Singh YM
    J Commun Dis; 2005 Mar; 37(1):73-7. PubMed ID: 16637404
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Perceived barriers to safe-injection practices among drug injectors who remain HCV-negative.
    Stein MD; Dubyak P; Herman D; Anderson BJ
    Am J Drug Alcohol Abuse; 2007; 33(4):517-25. PubMed ID: 17668337
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Modelling the impact on Hepatitis C transmission of reducing syringe sharing: London case study.
    Vickerman P; Hickman M; Judd A
    Int J Epidemiol; 2007 Apr; 36(2):396-405. PubMed ID: 17218325
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.